{"id":4131,"date":"2021-03-31T20:02:57","date_gmt":"2021-03-31T17:02:57","guid":{"rendered":"https:\/\/www.klimik.org.tr\/koronavirus\/?p=4131"},"modified":"2021-03-31T20:08:09","modified_gmt":"2021-03-31T17:08:09","slug":"pfizer-biontech-ergenlerde-oncu-covid-19-asi-calismasinin-olumlu-sonuclarini-acikladi","status":"publish","type":"post","link":"https:\/\/www.klimik.org.tr\/koronavirus\/pfizer-biontech-ergenlerde-oncu-covid-19-asi-calismasinin-olumlu-sonuclarini-acikladi\/","title":{"rendered":"Pfizer-BioNTech Ergenlerde \u00d6nc\u00fc COVID-19 A\u015f\u0131 \u00c7al\u0131\u015fmas\u0131n\u0131n Olumlu Sonu\u00e7lar\u0131n\u0131 A\u00e7\u0131klad\u0131"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"lazy\" class=\"size-full wp-image-103827 alignleft\" src=\"https:\/\/www.klimik.org.tr\/wp-content\/uploads\/2021\/03\/Pfizer__logo.jpg\" alt=\"\" width=\"120\" height=\"49\" \/><strong>BNT162b2 COVID-19 a\u015f\u0131s\u0131 12-15 ya\u015f aras\u0131 kat\u0131l\u0131mc\u0131larda, daha \u00f6nceki bir analizde a\u015f\u0131lanm\u0131\u015f 16-25 ya\u015f\u0131ndaki kat\u0131l\u0131mc\u0131lar\u0131n deneyinde bildirilen oranlar\u0131 a\u015farak %100 etkililik ve g\u00fc\u00e7l\u00fc antikor tepkileri g\u00f6sterdi, ayr\u0131ca iyi tolere edildi.<\/strong><\/p>\n<p>Bug\u00fcn, \u00f6nceden SARS-CoV-2 infeksiyonu ge\u00e7irdi\u011fine dair kan\u0131t olsun veya olmas\u0131n, 12 ila 15 ya\u015f aras\u0131ndaki ergenlerde yap\u0131lan bir Faz 3 deneyinde, Pfizer-BioNTech COVID-19 a\u015f\u0131s\u0131 BNT162b2&#8217;nin %100 etkililik ve 16-25 ya\u015flar\u0131 aras\u0131ndaki a\u015f\u0131lanm\u0131\u015f kat\u0131l\u0131mc\u0131larda daha \u00f6nce kaydedilen de\u011ferleri a\u015fan g\u00fc\u00e7l\u00fc antikor tepkileri g\u00f6sterdi\u011fini\u00a0 ve iyi tolere edildi\u011fini duyurdular.\u00a0 Sonu\u00e7lar, 2260 ergen \u00fczerinde yap\u0131lan \u00f6nemli bir faz 3 \u00e7al\u0131\u015fmas\u0131n\u0131n en \u00f6nemli ba\u015fl\u0131klar\u0131d\u0131r.<\/p>\n<p>Pfizer ve BioNTech \u015firketleri bu verileri, BNT162b2 a\u015f\u0131s\u0131 i\u00e7in Acil Kullan\u0131m \u0130zni (EUA) ve AB Ko\u015fullu Pazarlama Yetkisinin geni\u015fletilmesini talep etmek \u00fczere bu ABD G\u0131da ve \u0130la\u00e7 Dairesi&#8217;ne (FDA) ve Avrupa \u0130la\u00e7 Ajans\u0131na (EMA) m\u00fcmk\u00fcn olan en k\u0131sa s\u00fcrede sunmay\u0131 planlamaktad\u0131r.<\/p>\n<p><a href=\"https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-biontech-announce-positive-topline-results-pivotal\"><strong>Haber \u0130\u00e7in T\u0131klay\u0131n\u0131z<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BNT162b2 COVID-19 a\u015f\u0131s\u0131 12-15 ya\u015f aras\u0131 kat\u0131l\u0131mc\u0131larda, daha \u00f6nceki bir analizde a\u015f\u0131lanm\u0131\u015f 16-25 ya\u015f\u0131ndaki kat\u0131l\u0131mc\u0131lar\u0131n deneyinde bildirilen oranlar\u0131 a\u015farak %100 etkililik ve g\u00fc\u00e7l\u00fc antikor tepkileri g\u00f6sterdi, ayr\u0131ca iyi tolere edildi. Bug\u00fcn, \u00f6nceden SARS-CoV-2 infeksiyonu ge\u00e7irdi\u011fine dair kan\u0131t olsun veya olmas\u0131n, 12 ila 15 ya\u015f aras\u0131ndaki ergenlerde yap\u0131lan bir Faz 3 deneyinde, Pfizer-BioNTech COVID-19 a\u015f\u0131s\u0131 BNT162b2&#8217;nin %100 etkililik ve 16-25 ya\u015flar\u0131 aras\u0131ndaki a\u015f\u0131lanm\u0131\u015f kat\u0131l\u0131mc\u0131larda daha \u00f6nce kaydedilen de\u011ferleri a\u015fan g\u00fc\u00e7l\u00fc antikor tepkileri g\u00f6sterdi\u011fini\u00a0 ve iyi tolere edildi\u011fini duyurdular.\u00a0 Sonu\u00e7lar, 2260 ergen \u00fczerinde yap\u0131lan \u00f6nemli bir faz 3 \u00e7al\u0131\u015fmas\u0131n\u0131n en \u00f6nemli ba\u015fl\u0131klar\u0131d\u0131r. Pfizer ve BioNTech \u015firketleri bu verileri, BNT162b2 a\u015f\u0131s\u0131 i\u00e7in Acil [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":4132,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/4131"}],"collection":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/comments?post=4131"}],"version-history":[{"count":2,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/4131\/revisions"}],"predecessor-version":[{"id":4134,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/4131\/revisions\/4134"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media\/4132"}],"wp:attachment":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media?parent=4131"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/categories?post=4131"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/tags?post=4131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}